Skip to main content
CAMP
NASDAQ Life Sciences

Camp4 Registers 32.7M Resale Shares — 38.6% Overhang Now Tradable

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$4.53
Mkt Cap
$284.272M
52W Low
$1.35
52W High
$7.75
52W Position info
236% above low
Off High info
42% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

CAMP has more than doubled off its 52-week low of $1.35 on elevated volume (2.3× avg).

Summary

Camp4's resale registration is effective, making 32.7 million shares from its recent private placement freely tradable — a 38.6% overhang that could pressure the stock.


Key Events · Financing and Capital Events · CAMP

  • Resale Registration Effective

    The S-3 registration statement covering 32.7 million shares from the August 3 private placement is now effective, allowing selling stockholders to sell immediately.

  • 38.6% Overhang

    The resale shares represent approximately 38.6% of total outstanding common stock, creating a significant potential supply overhang.

  • No Proceeds to Company

    Camp4 will not receive any proceeds from these resales; the $50.1 million was already raised in the private placement.

  • Profit Incentive for Sellers

    Resale shares were acquired at $1.53-$1.65 per share, versus the August 11 closing price of $4.17, giving holders a strong incentive to sell.


Analysis · CAMP · Life Sciences

The registration statement covering 32.7 million shares from the August 3 private placement is now effective. Selling stockholders can immediately sell into the market, creating a substantial overhang of approximately 38.6% of outstanding shares. While the company received $50.1 million in gross proceeds, it will not receive any proceeds from these resales. The stock closed at $4.17 on August 11, and the resale shares were acquired at $1.53-$1.65, giving holders a significant profit incentive to sell.

At the time of this filing, CAMP was trading at $4.53 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $284.3M. The 52-week trading range was $1.35 to $7.75. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CAMP - Latest Insights

CAMP
Aug 06, 2026, 4:36 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $4.50
Real-time Price: $4.30 info
Change: -$0.200 (-4%) info
Market Cap: $284.272M info
CAMP
Aug 05, 2026, 5:43 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $4.16
Real-time Price: $4.30 info
Change: +$0.140 (+3%) info
Market Cap: $284.272M info
CAMP
Aug 04, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.12
Real-time Price: $4.30 info
Change: +$0.180 (+4%) info
Market Cap: $284.272M info
CAMP
Jul 27, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.40
Real-time Price: $4.30 info
Change: +$0.900 (+26%) info
Market Cap: $284.272M info
CAMP
May 14, 2026, 9:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.50
Real-time Price: $4.30 info
Change: -$0.200 (-4%) info
Market Cap: $284.272M info